Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access               Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain LOXO message board posts where the ticker symbol LOXO has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest LOXO SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001567619-18-001208 Size: 25 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001567619-18-001207 Size: 20 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001567619-18-001205 Size: 25 KB
S-8  Documents Securities to be offered to employees in employee benefit plans
Acc-no: 0001104659-18-050972 (33 Act)  Size: 160 KB
2018-08-09 333-226734
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001104659-18-050933 (34 Act)  Size: 5 MB
2018-08-09 001-36562
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001104659-18-050732 (34 Act)  Size: 246 KB
2018-08-09 001-36562
SC 13D/A  Documents [Amend] General statement of acquisition of beneficial ownership
Acc-no: 0001193125-18-216915 (34 Act)  Size: 115 KB
2018-07-12 005-88267
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-019810 Size: 13 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001140361-18-032164 Size: 15 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001140361-18-032160 Size: 29 KB
More LOXO SEC Filings

Related news from
Fri, 10 Aug 2018
20:30:00 +0000
Loxo Oncology Announces Accepted Abstracts at the IASLC 19th World Conference on Lung Cancer
STAMFORD, Conn., Aug. 10, 2018-- Loxo Oncology, Inc., a biopharmaceutical company developing highly selective medicines for patients with genomically defined cancers, today announced that abstracts from ...
Thu, 09 Aug 2018
15:28:55 +0000
Analyst Recommendations for Exelixis in August
In the second quarter, Exelixis’s (EXEL) cabozantinib franchise generated revenues of $145.8 million, which was a ~66% YoY (year-over-year) growth. Exelixis’s net product revenues grew 9% sequentially in the second quarter. In the second quarter, Ipsen, Exelixis’s partner, generated cumulative revenues of $150 million from sales of cabozantinib.
Thu, 09 Aug 2018
12:10:12 +0000
Loxo Oncology (LOXO) Reports Q2 Loss, Tops Revenue Estimates
Loxo (LOXO) delivered earnings and revenue surprises of -1500.00% and 7.59%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Thu, 09 Aug 2018
11:04:28 +0000
Loxo: 2Q Earnings Snapshot
The Stamford, Connecticut-based company said it had a loss of 39 cents per share. Losses, adjusted for non-recurring gains, came to $1.68 per share. The developer of cancer treatments posted revenue of ...
Thu, 09 Aug 2018
10:45:00 +0000
Loxo Oncology Reports Second Quarter 2018 Financial Results
-LOXO-292 New Drug Application Submission to FDA Expected in Late 2019-. -Updated Larotrectinib Duration of Response Data to be Reported at ESMO-. -Larotrectinib NDA PDUFA date is November 26, 2018-.
Thu, 09 Aug 2018
10:00:00 +0000
Loxo Oncology Inc to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / August 9, 2018 / Loxo Oncology Inc (NASDAQ: LOXO ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 9, 2018 at 8:00 AM Eastern Time. ...
Wed, 08 Aug 2018
13:18:01 +0000
Drug/Biotech Stock Q2 Earnings on Aug 9: PRGO, BDSI & More
Several drug/biotech companies are set to report second-quarter results on Aug 9. Let's see how things are shaping up for their announcements.
Sat, 04 Aug 2018
12:03:45 +0000
See what the IHS Markit Score report has to say about Loxo Oncology Inc.
Loxo Oncology Inc NASDAQ NMS:LOXO
Thu, 02 Aug 2018
10:45:00 +0000
Loxo Oncology to Announce Second Quarter 2018 Financial Results
STAMFORD, Conn., Aug. 02, 2018-- Loxo Oncology, Inc., a biopharmaceutical company developing highly selective medicines for patients with genomically defined cancers, will announce financial results for ...
Tue, 17 Jul 2018
11:35:00 +0000
Breakfast Technical Briefing on Mirati Therapeutics and Three Other Additional Biotech Stocks
Stock Research Monitor: KTOV, LOXO, and MDGL LONDON, UK / ACCESSWIRE / July 17, 2018/ If you want a free Stock Review on MRTX sign up now at . Today, ...
Wed, 11 Jul 2018
12:10:00 +0000
Today's Research Reports on Stocks to Watch: Loxo Oncology and OnoCyte
NEW YORK, NY / ACCESSWIRE / July 11, 2018 / Shares of Loxo Oncology were in the red on Tuesday almost 6% despite any news. Shares of OncoCyte were gaining full speed after announcing that the DetermaVu diagnostic test for lung cancer saw better performance than the company was expecting. Loxo Oncology, Inc. shares closed down almost 6% on Tuesday with around 1 million shares traded.
Mon, 11 Jun 2018
12:20:00 +0000
Today's Research Reports on Trending Tickers: Loxo Oncology and Geron Corporation
NEW YORK, NY / ACCESSWIRE / June 11, 2018 / U.S. markets finished higher and logged strongest week in months as investors shrug off tensions between U.S. and its allies. The Dow Jones Industrial Average ...
Fri, 08 Jun 2018
12:47:07 +0000
Here's Why Loxo Oncology Stock Gained 40.8% in May
The promising biopharma had a presentation selected for the coveted "Best of ASCO" track, then delivered the goods in early June.
Fri, 08 Jun 2018
10:04:00 +0000
3 Cancer Stocks That Could Soar in the Second Half of 2018
Keep your eyes open for big catalysts that could give these biotech stocks a push in the right direction.
Thu, 07 Jun 2018
12:10:00 +0000
New Research Coverage Highlights Durect, Credit Suisse Group, Obsidian Energy, TransCanada, Golden Star Resources, and Loxo Oncology — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, June 07, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Durect ...
Mon, 04 Jun 2018
20:23:00 +0000
Why #ASCO18 Caused Blueprint Medicines Shares To Tumble Up to 16% Today
News from key competitors sent this company's shares reeling.
Mon, 04 Jun 2018
20:21:24 +0000
Here Are Winners And Losers From 2018's Biggest Cancer Drug Meeting
Merck jumped to a five-month high Monday on strong data for cancer drug Keytruda in melanoma as shares of Nektar Therapeutics went into free fall on its combination with Bristol-Myers Squibb
Mon, 04 Jun 2018
19:32:00 +0000
Merck emerges as key winner at ASCO conference
CNBC's Meg Tirrell reports from the ASCO cancer meeting underway in Chicago.

"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "ValueForum is comprised of a large and growing, diverse, knowledgeable group of investors. The attribute you should appreciate that this wonderful group makes available to you as an incoming member is Generosity. Research, firsthand sector sophistication, source references and sometimes remarkably insightful analyses are given freely by the members so you may do your own due dilligence in making informed investment decisions." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards